Improving care for dementia patients through a new assessment tool for caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to adapt and evaluate the Care Partner Hospital Assessment Tool (CHAT) specifically for caregivers of hospitalized patients with Alzheimer's disease and related dementias. The research involves two design teams that include care partners and healthcare professionals who will collaborate to refine the tool through a series of co-design sessions. Following adaptation, the study will recruit 128 care partners to participate in a pilot randomized clinical trial, comparing the effectiveness of the CHAT-AD combined with usual care against usual care alone over a 14-day period. The goal is to enhance hospital care processes and outcomes for patients living with dementia and their caregivers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Provide unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of ADRD
* 18 years or older

Exclusion Criteria:

* Non-English speaking

Where it's running

• University of Wisconsin
  Madison, Wisconsin, United States Recruiting

Study contacts

• Principal investigator: Beth Fields, PhD — University of Wisconsin, Madison
• Study coordinator: Anne Mortensen
• Email: amortensen3@wisc.edu
• Phone: 608-262-2712

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood biomarker cohort for memory disorders in older adults

  This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.

  Recruiting Yonsei University · Seoul, Seodamun-gu · NCT07880275

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Norms for a Voice-Based Digital Cognitive Test Across Ages

  This study tests a voice-enabled digital cognitive test to establish normal scores for adults aged 18–100.

  Recruiting The Neurology Center of Southern California · Carlsbad, California · NCT07763392

• Lived Experience Narratives in Dementia

  This project tests a digital Online LEND Intervention that shares dementia patients’ and caregivers’ lived experiences to see if it helps wellbeing and connection.

  Recruiting at 2 sites University of Nottingham · Nottingham, England and 1 other locations · NCT07757178

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Far-Infrared Therapy for Alzheimer’s Disease Dementia

  This trial tests whether a far-infrared radiator can help people with Alzheimer's-related dementia who are on stable dementia medications.

  Recruiting National Defense Medical Center, Taiwan · Taipei · NCT07672171

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.